Clinical Trials for Longboard Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Longboard Pharmaceuticals

Clinical Trials (3)

NCT06908226
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
PHASE3Enrolling by invitation
324 participants
Started: Feb 12, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor33 locations
NCT06719141
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
PHASE3Recruiting
320 participants
Started: Nov 11, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor57 locations
NCT06660394
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
PHASE3Recruiting
160 participants
Started: Sep 25, 2024 · Completed: Oct 2, 2026
1 condition1 sponsor63 locations